107 related articles for article (PubMed ID: 15327590)
1. Statins and newly diagnosed diabetes.
Jick SS; Bradbury BD
Br J Clin Pharmacol; 2004 Sep; 58(3):303-9. PubMed ID: 15327590
[TBL] [Abstract][Full Text] [Related]
2. Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.
Jick SS; Choi H; Li L; McInnes IB; Sattar N
Ann Rheum Dis; 2009 Apr; 68(4):546-51. PubMed ID: 18662929
[TBL] [Abstract][Full Text] [Related]
3. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
4. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering drugs and the risk of depression and suicidal behavior.
Yang CC; Jick SS; Jick H
Arch Intern Med; 2003 Sep; 163(16):1926-32. PubMed ID: 12963565
[TBL] [Abstract][Full Text] [Related]
7. Chronic statin therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
9. The risk of cancer in users of statins.
Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ
J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200
[TBL] [Abstract][Full Text] [Related]
10. Differences between statins on clinical endpoints: a population-based cohort study.
Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
[TBL] [Abstract][Full Text] [Related]
11. Statin use in Type 2 diabetes mellitus is associated with a delay in starting insulin.
Yee A; Majumdar SR; Simpson SH; McAlister FA; Tsuyuki RT; Johnson JA
Diabet Med; 2004 Sep; 21(9):962-7. PubMed ID: 15317599
[TBL] [Abstract][Full Text] [Related]
12. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.
Khurana V; Sheth A; Caldito G; Barkin JS
Pancreas; 2007 Mar; 34(2):260-5. PubMed ID: 17312467
[TBL] [Abstract][Full Text] [Related]
13. Statins and the risk of acute pancreatitis: a population-based case-control study.
Thisted H; Jacobsen J; Munk EM; Nørgaard B; Friis S; McLaughlin JK; Sørensen HT; Johnsen SP
Aliment Pharmacol Ther; 2006 Jan; 23(1):185-90. PubMed ID: 16393296
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
Donnelly LA; Palmer CN; Whitley AL; Lang CC; Doney AS; Morris AD; Donnan PT
Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
[TBL] [Abstract][Full Text] [Related]
17. Long-term statin use and the risk of gallstone disease: A population-based case-control study.
Erichsen R; Frøslev T; Lash TL; Pedersen L; Sørensen HT
Am J Epidemiol; 2011 Jan; 173(2):162-70. PubMed ID: 21084557
[TBL] [Abstract][Full Text] [Related]
18. Statins and cancer risk.
Karp I; Behlouli H; Lelorier J; Pilote L
Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
[TBL] [Abstract][Full Text] [Related]
19. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
Douketis JD; Melo M; Bell CM; Mamdani MM
Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234
[TBL] [Abstract][Full Text] [Related]
20. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL
Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
